GO2 for Lung Cancer, Dana-Farber Cancer Institute, and Addario Lung Cancer Medical Institute Announce Expansion of Landmark Patient Research on Underlying Causes of Inherited Risk of Lung Cancer
Clinical Trial Aims to Unlock the Origins of Lung Cancer WASHINGTON and BOSTON, April 17, 2024 – In a promising step forward, GO2 for Lung Cancer (GO2), Dana-Farber Cancer Institute (Dana-Farber), and the Addario Lung Cancer Medical Institute (ALCMI), [...]